Mediland Pharm Ltd (ASX: MPH) Commenced Trading on ASX
On the final week of February 2019, the highly anticipated ASX listing of Mediland Pharm Ltd (ASX: MPH) commenced trading on the Australian Stock Exchange (ASX) at the IPO price of A$0.20 per share.
“We are very pleased to have completed the IPO and are excited to now begin executing and delivering on our growth strategy,” said Dr. Peter French, Chairman of MPH.
Trading commenced with a strong pipeline of commercial opportunities following its successful strategy of targeting partnering with tour operators to provide Chinese tourists bound for Australia – New Zealand a one-stop shopping and tourism experience.
MPH is a leading retailer in health, well-being and wool products, jewellery and cosmetics targeting the inbound Chinese tourist market in Australia and New Zealand for over 15 years.
MPH is expected to deliver a strong price action and very favourable returns in the coming months.
View MPH on ASX